CAH Financials Cardinal Health

15 years of revenue, profit, cash flow and balance-sheet history through FY2026, from SEC filings — with a computed, factual read of the trend. Updated 34 d ago Overview →

Growth & profitability

Revenue has grown 9.4% per year over the past 5 years.
Net income has grown faster than revenue (22.9% vs 9.4% per year).
Operating margin has been roughly flat, at 1.0% in the latest year.
Free cash flow has grown 17.4% per year over the past 5 years.

Financial health

Total debt has grown slower than revenue (4.6% vs 9.4% per year).
Operating income covered interest expense 7.5× in the latest year, up from 2.6× 5 years ago.

Shareholder returns

Dividends have been paid for 15 consecutive years, consuming 28.6% of earnings and 10.9% of free cash flow.
The dividend has declined 3.0% per year over the past 5 years.

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key annual figures

FY	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
2026	$254.2B	$1.7B	3.8%	1.0%	-59.5%	3.0%	$4.5B	—	$4.9B
2025	$222.6B	$1.6B	3.7%	1.0%	-56.1%	2.9%	$1.9B	$8.5B	$3.9B
2024	$226.8B	$852M	3.3%	0.5%	-26.5%	1.9%	$3.3B	$5.1B	$5.1B
2023	$205.0B	$330M	3.4%	0.4%	-11.2%	0.8%	$2.4B	$4.7B	$4.1B
2022	$181.3B	-$938M	3.6%	-0.3%	132.3%	-2.1%	$2.8B	$5.3B	$4.7B
2021	$162.5B	$611M	4.2%	0.3%	34.1%	1.4%	$2.0B	$6.2B	$3.4B
2020	$152.9B	-$3.7B	4.5%	-2.7%	-206.6%	-9.1%	$1.6B	$6.8B	$2.8B
2019	$145.5B	$1.4B	4.7%	1.4%	21.5%	3.3%	$2.4B	—	$2.5B
2018	$136.8B	$256M	5.2%	0.1%	4.2%	0.6%	$2.4B	—	$1.8B
2017	$130.0B	$1.3B	5.0%	1.6%	18.9%	3.2%	$797M	—	$6.9B
2016	$121.5B	$1.4B	5.4%	2.0%	21.8%	4.2%	$2.5B	—	$2.4B
2015	$102.5B	$1.2B	5.6%	2.1%	19.4%	4.0%	$2.2B	—	$4.6B
2014	$91.1B	$1.2B	5.7%	2.1%	18.2%	4.5%	$2.3B	—	$2.9B
2013	$101.1B	$334M	4.9%	1.0%	5.6%	1.3%	$1.5B	—	$1.9B
2012	$107.6B	$1.1B	4.2%	1.7%	17.1%	4.4%	$916M	—	$2.3B

Revenue & net income

RevenueNet income

Margins (gross / operating / net)

GrossOperatingNet

Return on equity & assets (ROE / ROA)

ROEROA

Free cash flow (CFO − capex, quarterly)

Free cash flow

Cash vs total debt

CashTotal debt

Cash flow: operating / investing / financing

OperatingInvestingFinancing

Key quarterly figures

Quarter	Revenue	Net income	Gross M	Op M	ROE	ROA	FCF	Total debt	Cash
Dec '25	$65.6B	$467M	3.7%	1.1%	-16.2%	0.8%	$555M	—	$2.8B
Sep '25	$64.0B	$450M	3.6%	1.0%	-15.6%	0.8%	$865M	$9.0B	$4.6B
Jun '25	$60.2B	$239M	3.7%	0.7%	-8.6%	0.4%	$1.3B	$8.5B	$3.9B
Mar '25	$54.9B	$506M	3.9%	1.3%	-17.2%	1.0%	$2.8B	—	$3.3B
Dec '24	$55.3B	$400M	3.5%	1.0%	-13.4%	0.9%	-$495M	—	$3.8B
Sep '24	$52.3B	$416M	3.6%	1.1%	-12.7%	1.0%	-$1.7B	$5.2B	$2.9B
Jun '24	$59.9B	$235M	3.1%	0.7%	-7.3%	0.5%	$1.9B	$5.1B	$5.1B
Mar '24	$54.9B	$261M	3.5%	0.7%	-8.0%	0.6%	-$139M	—	$3.7B
Dec '23	$57.4B	$368M	3.2%	0.9%	-10.7%	0.8%	$1.1B	$4.7B	$4.6B
Sep '23	$54.6B	-$12M	3.2%	-0.1%	0.3%	-0.0%	$436M	$4.7B	$3.9B
Jun '23	$53.4B	$5M	3.4%	0.3%	-0.2%	0.0%	$646M	$4.7B	$4.1B
Mar '23	$50.5B	$365M	3.6%	1.2%	-16.4%	0.8%	$1.3B	—	$4.0B
Dec '22	$51.5B	-$77M	3.3%	-0.2%	3.5%	-0.2%	$512M	—	$3.7B
Sep '22	$49.6B	$110M	3.3%	0.3%	-6.2%	0.3%	-$47M	$5.3B	$3.5B
Jun '22	$47.1B	$138M	3.4%	0.1%	-19.5%	0.3%	$2.8B	$5.3B	$4.7B
Mar '22	$44.8B	-$1.4B	3.8%	-0.2%	199.6%	-3.3%	-$501M	—	$2.4B
Dec '21	$45.5B	$49M	3.6%	-2.1%	4.9%	0.1%	$1.1B	—	$3.2B
Sep '21	$44.0B	$271M	3.7%	0.9%	19.5%	0.6%	-$713M	$5.7B	$2.5B
Jun '21	$42.6B	$116M	3.5%	0.4%	6.5%	0.3%	$539M	$6.2B	$3.4B
Mar '21	$39.3B	$119M	4.6%	1.2%	6.6%	0.3%	$177M	—	$3.5B

Valuation over time

How the market has priced CAH against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

The price-to-earnings ratio has fallen from 66.7× (Jun '23) to 33.7× (Sep '26).
The price-to-sales ratio has risen from 0.1× (Mar '23) to 0.2× (Sep '26).
The dividend yield has fallen from 3.2% (Mar '23) to 0.8% (Sep '26).

Price / earnings (P/E)

P/E

Price / sales (P/S)

P/S

Dividend yield (%)

Dividend yield %

Frequently asked questions

Is CAH growing its revenue and profit?

Over the past 5 years, Cardinal Health's revenue has grown 9.4% per year, and net income grown 22.9% per year. These are computed facts, not advice.

How much debt does CAH have?

As of FY2026, Cardinal Health reported — of total debt against $4.9B of cash; operating income covered interest expense 7.5×.

What is CAH's profit margin?

In FY2026, gross margin was 3.8%, operating margin 1.0%, and net margin 0.7%.

What is CAH's P/E ratio?

As of Sep '26, Cardinal Health traded at a price-to-earnings ratio of about 33.7× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.